logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Horizon Therapeutics USA, Inc. drugs

    FiltersReset Filters
    10 results

    • actimmune

      (Interferon gamma-1b)
      Horizon Therapeutics USA, Inc.
      Usage: ACTIMMUNE is indicated for reducing serious infections in patients with Chronic Granulomatous Disease (CGD) and for delaying disease progression in severe, malignant osteopetrosis (SMO).

    • buphenyl - sodium phenylbutyrate tablet

      (Sodium Phenylbutyrate)
      Horizon Therapeutics Usa, Inc.

    • krystexxa

      (pegloticase)
      Horizon Therapeutics USA, Inc.
      Usage: KRYSTEXXA (pegloticase) is indicated for treating chronic gout in adult patients who are refractory to conventional therapy, meaning they have not achieved normalized serum uric acid levels or adequately controlled symptoms with maximum doses of xanthine oxidase inhibitors. It is not recommended for asymptomatic hyperuricemia.

    • pennsaid

      (diclofenac sodium)
      Horizon Therapeutics USA, Inc.
      Usage: PENNSAID is indicated for the treatment of pain associated with osteoarthritis of the knee(s).

    • procysbi

      (Cysteamine bitartrate)
      Horizon Therapeutics USA, Inc.
      Usage: PROCYSBI is indicated for the treatment of nephropathic cystinosis in adults and pediatric patients aged 1 year and older.

    • ravicti - glycerol phenylbutyrate liquid

      (Glycerol Phenylbutyrate)
      Horizon Therapeutics Usa, Inc.

    • rayos

      (prednisone)
      Horizon Therapeutics USA, Inc.
      Usage: RAYOS is indicated for severe allergic conditions, various dermatologic and endocrine diseases, gastrointestinal disorders (like Crohn's and ulcerative colitis), hematologic issues, neoplasms, nervous system conditions (such as multiple sclerosis), certain ophthalmic diseases, organ transplant rejection, pulmonary disorders, renal conditions, rheumatologic ailments, and specific infectious diseases.

    • tepezza

      (teprotumumab)
      Horizon Therapeutics USA, Inc.
      Usage: TEPEZZA is indicated for the treatment of Thyroid Eye Disease, applicable to patients regardless of the disease's activity level or duration.

    • uplizna

      (Inebilizumab)
      Horizon Therapeutics USA, Inc.
      Usage: UPLIZNA is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients with anti-aquaporin-4 (AQP4) antibody positivity and for immunoglobulin G4-related disease (IgG4-RD) in adults.

    • vimovo

      (Naproxen and Esomeprazole Magnesium)
      Horizon Therapeutics USA, Inc.
      Usage: VIMOVO, a combination of naproxen and esomeprazole magnesium, is indicated for symptomatic relief of arthritis in adults and adolescents (ages 12+), while helping to reduce the risk of naproxen-associated gastric ulcers. It's not recommended for initial acute pain treatment and is not a substitute for single-ingredient products.